Sinovac Biotech Endeavours To Develop Swine Flu Vaccine

News: Chinese biopharmaceutical company Sinovac Biotech has announced the commencement of preliminary activities related to the development of a vaccine for H1N1 Swine Flu, which is currently considered a serious health concern. The company is in talks with Chinese government authorities as well as other global health organisations regarding strategies to restrict the virus's transmission.

To read the full article, please choose one of the following options: